Radiopharm Theranostics Ltd (RADX) Form 424B5 — Jul 27, 2026
Radiopharm Theranostics Limited is offering 1,281,646 American Depositary Shares (ADSs) at $3.16 per share, representing a discount of approximately 26% to the last reported sale price of $4.29 on the Nasdaq. The offering is expected to generate gross proceeds of approximately $4.05 million, with net proceeds of approximately $3.3 million after deducting placement agent fees and estimated offering expenses. The company has retained H.C. Wainwright & Co., LLC as its exclusive placement agent and has agreed to pay a cash fee of 7.0% of the aggregate gross proceeds.
Key figures
- Gross Proceeds
- $4,050,001.36
- Offering Price
- $3.16
- Shares Offered
- 1,281,646
- Net Proceeds
- ~$3.3 million
- Public Float
- $40,165,592
- Warrants Offered
- 1,281,646
- Shares Outstanding
- 3,928,709,960
- Warrant Exercise Price
- $3.79
- Placement Agent Warrants
- 64,082
- Placement Agent Warrant Exercise Price
- $3.95
Price after filing
Close on the filing date to close N calendar days later (from $3.66). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.